1.
Identification and analysis on the Rh blood group of newborns with hemolytic disease
新生儿溶血病患儿Rh血型的检测分析
2.
Investigation on the relation between antibodies of gravida serum IgG blood type and hemolytic disease of newborn
孕妇血清IgG血型抗体与新生儿溶血病关系探讨
3.
Study on ZIANYINU Pill Prevent and Trent ABO Maternal- Fetal Blood Group Incompatibility Hemolytic Disease;
子安益母丸防治ABO母儿血型不合溶血病的研究
4.
Application and demand of using blood of umbilical cord in diagnosing case of newborns infected with ABO-Haemolytic Disease
脐带血在新生儿ABO溶血病诊断中的应用价值
5.
The Relationship Between the Titer of Serum Antibody of Gravidas and Hemolytic Disease of the Newborn
孕妇血清抗体效价与新生儿溶血病的关系
6.
Relationship between Titer of Blood Group Antibodies of Pregnant Women with ABO or Rh Blood Type Incompatibility and Exchange Transfusion in Hemolytic Disease of Newborn Infants
ABO、Rh血型不合孕妇血型抗体效价与新生儿溶血病换血的关系
7.
microangiopathic hemolytic anemia
微血管病性溶血性贫血
8.
A fusion factor exists separate from the virus'ability to hemolyze.
融合因素未必能与病毒溶血能力分开。
9.
Detection of Pathogenic Vibrio Parahaemolyticus in Aquatic Products
水产品中致病性副溶血性弧菌的检测
10.
Correlativity between blood-stasis syndrome in cardiopathy and activity of f ibrinolytic system
心病血瘀证与纤溶系统活性的相关性
11.
The Value of Serum Soluble CD40 Ligand in Patients with Coronary Heart Disease
血清可溶性CD40L在冠心病患者中的价值
12.
Relation between the levels of serum soluble CD14 and blood glucose or lipid in patients with diabetic nephropathy
糖尿病肾病患者血清可溶性CD14水平与血糖、血脂的关系
13.
The clinical application of ischemic cerebrovascular intraarterial thrombolytic therapy
缺血性脑血管动脉病溶栓介入治疗临床应用
14.
Internal carotid artery thrombolysis therapy for children with ischemic cerebrovascular disease
儿童缺血性脑血管病颈内动脉溶栓治疗
15.
Relationship between fibrinolytic system and the macro-vascular complications in type 2 diabetes mellitus
纤溶活性与2型糖尿病及其大血管病变的关系
16.
Type2 Diabetic Hemoglutination, the Filament Dissolves with the Trunk Pathological Change Relations.;
2型糖尿病患者凝血、纤溶指标异常与大血管病变的关系
17.
A Study on Relationship between Serum Lipoprotein(a) Level, The Changes of Plasma Haemostatic and Fibrinolytic Activities and T2 Diabetic Nephropathy;
血清脂蛋白（a）水平和凝血纤溶的改变与2型糖尿病肾病关系的研究
18.
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系